Three Symposia, Three Years of Fellows, One Mission: Medscape Oncology at ASCO 2026
May 14, 2026 | #ASCO26 #medscapeoncology, MedEd
Three symposia. A third year of Fellows. AI live on the booth floor. Medscape Oncology arrives at ASCO 2026 (Booth #10099) with another ambitious oncology program.
Three Symposia at the Hilton Chicago
- The Reality of Care for HER2-Mutated Advanced NSCLC: Closing Community Gaps — Saturday, May 30, 6:15–7:45 PM CT, International Ballroom South. Supported by Bayer.
- Redefining the Patient Journey: The Promise and Practice in NTRK Fusion-Positive Cancers — Sunday, May 31, 6:30–8:00 PM CT, International Ballroom South. Supported by Bayer.
- A Case-Based Guide for CD38-Targeted Monoclonal Antibody Therapy in the Treatment of Multiple Myeloma — Sunday, May 31, 6:30–7:30 PM CT, International Ballroom North. Supported by Sanofi, in partnership with the International Myeloma Foundation.
Online Poster
Medscape Oncology will also be presenting outcomes research as an e-poster: The Impact of Online CME on Addressing Clinical Decision-Making for Immunotherapy in Advanced Squamous NSCLC. Authors: Michelle A. Worst, PharmD, BCOP, MBA, CHCP; Andrew Small; Amy Furedy, RN, OCN; Charu Aggarwal, MD, MPH; Sandip Patel, MD
ASCO Fellows, Year Three
For the third consecutive year, Medscape Oncology is supporting a cohort of Fellows to attend ASCO. Fellows will spend time on the booth in focus groups, go hands-on with Medscape AI and the new medical simulation solution, Clinical Readiness Studio as well as engaging with faculty across the program.
“There is no better time to understand what oncology clinicians actually need than at the start of their specialist careers. Our Fellows tell us where the evidence gaps are, where the tools fall short, and what the next generation expects from medical education. That insight is irreplaceable, and it directly shapes what we build and what we publish. Alongside the symposia and Medscape AI, the Fellows program is central to why we show up at ASCO the way we do,” said Chris Hoffman, Chief Strategy Officer, Medscape Education.
Medscape AI on the Booth
Medscape AI represents a new generation of clinical intelligence and research tools, drawing exclusively on a clinically validated knowledge base of expert-authored content, peer-reviewed journals, and rigorously vetted medical sources, with every response traceable to verifiable citations. Oncology is the most-queried specialty on Medscape AI, with breast cancer and lymphoma topping the list. A recent analysis of platform queries also found that diagnosis support and treatment decisions account for half of all physician queries across specialties.
An Indispensable Resource for Oncologists
Medscape has been delivering oncology education, medical information, and clinical tools for over 30 years. In a recent survey of hem/onc members, 79% recognised it as an indispensable resource, 78% would recommend it to colleagues, and 75% call it their preferred CME website. The trust is there. ASCO 2026 is where we put it to work.
Find the team at Booth #10099 or reach out to Jelena Spyropoulos at jspyropoulos@medscape.net.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Making an Impact at the Agents of Change Summit
Medscape Public Health is hitting the road to attend the public health conference Agents of Change. As part of their commitment to making an impact in public health, Medscape is…
Amplifying Women’s Voices in Healthcare: Medscape Education’s Award-Winning Podcast Series
“Be the change you want to see in the world.” Though the origins of this quote are a little fuzzy, the idea is crystal clear, and can inspire you to…
Humanizing Healthcare & Medical Education: The Power of Patient Integration
True ‘patient-centricity’ goes beyond treating disease—it means ensuring that patient voices shape research, decision-making, and medical education. We are in the era of Patient Integration, where the patient voice is…
Hitting Every Beat—The Power of Education in Heart Failure
Heart failure is a common medical condition, with new treatment approaches being developed every day. By 2030, an estimated 8.5 million Americans will be living with heart failure. With more…
Impactful Advances in Aesthetic Medicine
Medscape is pleased to announce new advancements within its Clinical Advances in Aesthetic Medicine. Launched in 2022, this initiative has effectively educated MD practitioners, showcasing measurable outcomes with submissions to…
A Pulse on Innovation at the Heart of Cardiology 2025
MedscapeLIVE! is proud to present its annual Heart of Cardiology meeting, returning for its fifth year in Miami, Florida from January 24-26, 2025. Over 3 packed days at the Fontainebleau…
A Sparkling Achievement: Sarah Atwood Celebrated as a 2024 CPD Forty Under 40
For Sarah Atwood, MPH, the proudest moment of her incredible career in education and instructional design is happening right now. Atwood is an instructional designer with a public health lens…
A Successful Outing at ASH 2024
Medscape has wrapped up their work at this year’s ASH annual meeting in San Diego. During the conference, Medscape hosted 8 symposia that presented the latest data and supported advancing…
Highlighting the Power of Patient-Integration
Advancing person-centered care is an important topic for the Medscape Oncology team, and no one knows this better than Dr Victoria Harvey-Jones, Associate Director of Clinical Strategy for Medscape Oncology…
Education, AI and More at ASH 2024
Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and oncology education. The presentations will reflect on the impact of last year’s programs,…